(Q43051350)

13 November 2017

The safety and tolerability of duloxetine compared with paroxetine and placebo: a pooled analysis of 4 clinical trials (English)

1 reference

13 November 2017

J Craig Nelson

1

1 reference

13 November 2017

Yili Lu Pritchett

2

1 reference

13 November 2017

Oleg Martynov

3

1 reference

13 November 2017

Jimmy Y Yu

4

1 reference

13 November 2017

Craig H Mallinckrodt

5

1 reference

13 November 2017

Michael J Detke

6

1 reference

13 November 2017

1 January 2006

1 reference

Primary Care Companion to the Journal of Clinical Psychiatry

13 November 2017

1 reference

13 November 2017

8

1 reference

13 November 2017

4

1 reference

13 November 2017

212-219

1 reference

A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction

13 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557468

A rating scale for depression

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557468

Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype?

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557468

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557468

Venlafaxine extended-release: a review of its use in the management of major depression

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557468

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557468

Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557468

Effects of SSRIs on sexual function: a critical review

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557468

Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557468

The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557468

Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557468

Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557468

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557468

Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557468

Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557468

A self-controlled, naturalistic study of selective serotonin reuptake inhibitors versus tricyclic antidepressants

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557468

Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557468

Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1557468

Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis

16 August 2018

1 reference

12 December 2020

Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease

1 reference

12 December 2020

Cardiovascular effects of antidepressant drugs: updated

1 reference

12 December 2020

The Arizona Sexual Experience Scale (ASEX): reliability and validity

1 reference

12 December 2020

Sexual dysfunction before antidepressant therapy in major depression

1 reference

12 December 2020

Identifiers

DOI

10.4088/PCC.V08N0404

1 reference

13 November 2017

1 reference

13 November 2017

PubMed publication ID

16964316

1 reference